Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEMG
101
DELISTED
SEMGROUP CORPORATION
SEMG
| $203M | 0.19% |
2,556,826
+49,807
| +2% | +$4.06M |
|
102
Cisco
CSCO
$454B
| $201M | 0.18% |
7,316,434
+193,735
| +3% | +$5.56M |
|
103
Kinder Morgan
KMI
$70.4B
| $199M | 0.18% |
5,182,977
-347,900
| -6% | -$14.5M |
|
104
Occidental Petroleum
OXY
$55.5B
| $191M | 0.17% |
2,457,849
+625,192
| +34% | +$48.8M |
|
105
Amphenol
APH
$187B
| $187M | 0.17% |
12,871,064
-452,400
| -3% | -$6.5M |
|
106
Henry Schein
HSIC
$9.85B
| $186M | 0.17% |
3,335,721
-117,752
| -3% | -$6.51M |
|
107
Suncor Energy
SU
$77.4B
| $185M | 0.17% |
6,738,341
-642,428
| -9% | -$19.4M |
|
|
CQH
108
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $182M | 0.17% |
7,792,178
+100,317
| +1% | +$2.47M |
|
|
POT
109
DELISTED
Potash Corp Of Saskatchewan
POT
| $180M | 0.17% |
5,816,389
+77,351
| +1% | +$2.48M |
|
110
Vodafone
VOD
$37.3B
| $179M | 0.16% |
4,913,319
+331,166
| +7% | +$11.9M |
|
111
Intuit
INTU
$91.3B
| $177M | 0.16% |
1,757,712
-62,490
| -3% | -$6.38M |
|
112
Citigroup
C
$215B
| $176M | 0.16% |
3,191,837
+681,096
| +27% | +$37.1M |
|
113
Global Payments
GPN
$24.1B
| $175M | 0.16% |
3,384,654
+1,064,066
| +46% | +$54.6M |
|
114
Eaton
ETN
$142B
| $174M | 0.16% |
2,572,309
+508,923
| +25% | +$35.9M |
|
|
MRO
115
DELISTED
Marathon Oil Corporation
MRO
| $171M | 0.16% |
6,451,995
+230,776
| +4% | +$6.51M |
|
116
Cinemark Holdings
CNK
$4.08B
| $170M | 0.16% |
4,232,968
+99,118
| +2% | +$4.13M |
|
|
TERP
117
DELISTED
TerraForm Power, Inc
TERP
| $167M | 0.15% |
4,390,999
+3,388,027
| +338% | +$134M |
|
|
KYTH
118
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $164M | 0.15% |
2,184,007
+23,569
| +1% | +$1.26M |
|
119
NiSource
NI
$21.6B
| $163M | 0.15% |
9,101,699
+1,006,741
| +12% | +$17.9M |
|
|
IHS
120
DELISTED
IHS INC CL-A COM STK
IHS
| $163M | 0.15% |
1,264,900
-58,035
| -4% | -$7.25M |
|
121
Ross Stores
ROST
$81.5B
| $162M | 0.15% |
3,330,554
-621,310
| -16% | -$31.2M |
|
122
AbbVie
ABBV
$467B
| $162M | 0.15% |
+2,407,696
| New | +$157M |
|
|
SRCL
123
DELISTED
Stericycle Inc
SRCL
| $159M | 0.15% |
1,186,362
-42,366
| -3% | -$5.81M |
|
|
SYA
124
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $158M | 0.15% |
6,552,982
-60,467
| -0.9% | -$1.47M |
|
125
Viatris
VTRS
$20.9B
| $158M | 0.14% |
2,325,721
+339,540
| +17% | +$24M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.